Name: Hereditary Factors in Carcinoma (Recent Results in Cancer Research, 12) (en Inglés)
SKU: 62113008
Price: 124900.00 CLP
Availability: InStock
Author: Henry T. Lynch
ISBN: 9783642482540

portada Hereditary Factors in Carcinoma (Recent Results in Cancer Research, 12) (en Inglés)

Hereditary Factors in Carcinoma (Recent Results in Cancer Research, 12) (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Henry T. Lynch

Idioma

Inglés

N° páginas

204

Encuadernación

Tapa Blanda

ISBN13

9783642482540

Hereditary Factors in Carcinoma (Recent Results in Cancer Research, 12) (en Inglés)

Henry T. Lynch (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 12 a 17 días háb.

$ 227.090$ 124.900

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 124.900

Llega entre el 02 Oct y el 09 Oct a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Hereditary Factors in Carcinoma (Recent Results in Cancer Research, 12) (en Inglés)"

The writing of this monograph was stimulated on the one hand by experience gained in the study of "cancer families", and on the other, by the frequent perplexed and bewildered comments made by numerous physicians who have expressed amaze- ment that we could think that "cancer is hereditary". In reviewing the world literature it became immediately apparent that no compendium on the subject of cancer genetics was available to the physician or research scientist. Therefore this monograph has been written for the following reasons: 1) To illuminate the problem for those who may have missed or ignored the evidence supporting a genetic etiology for certain malignant neoplasms; 2) to supply useful information to all practicing physicians regarding genetic risks to their patients; and 3) to provide new thoughts on the subject for use by cancer investigators. Finally, our paramount hope is that information gleaned through the reading of this monograph may contribute to the early dia gnosis of cancer in members of high risk "cancer families".